EQT Life Sciences
Part of EQT AB
EQT Life Sciences is the life sciences investment business line of EQT, formed in 2022 when EQT AB acquired the Amsterdam-based venture firm LSP (Life Sciences Partners, founded 1998) for EUR 475 million. It invests roughly EUR 10-60 million in therapeutics, medical devices, diagnostics and health tech, and has raised around EUR 3.5 billion across 12 private funds; René Kuijten, LSP's former Managing Partner, heads it.
Amsterdam, Netherlands · 6+ investments · 6 portfolio companies
- Headquarters
- Amsterdam, Netherlands
- Founded
- 1998
- Website
- eqtgroup.com
- AUM
- $3.8B
- Portfolio Companies
- 6
- Total Investments
- 6
- Last Investment
- Feb 2026
- Geographic Focus
- Europe
Investment Thesis
EQT Life Sciences is a Venture Capital firm based in Amsterdam, Netherlands. It has made 6 investments, including Vivasure, Onera Health and FundamentalVR. Focus areas include Diagnostics and Healthcare.
EQT AB Family
Portfolio6
Co-investors24
Sign up to view co-investors
24 co-investors across 31 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×14 · Private Equity ×6 · Other ×2 · 16 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/eqt-life-sciences"><img src="https://indexed.vc/api/badge/investor/eqt-life-sciences" alt="EQT Life Sciences on Indexed.vc" width="260" height="76" /></a>